Our expertise in translational pharmacology
Inoviem offers translational target discovery and drug-target Mode of Action (MoA) based on proprietary label-free technologies developed in a pathological and physiological environment that uses human tissue.
Our approach to working directly on non-modified human tissue means that we eliminate the need for modeling and its significant drawback of failing to take account of the natural environment in which a drug will have its beneficial effect.
We work within a natural environment and provide you with critical data without biasing the drug development process.
This results in a lower risk of drugs reaching the market with unexpected undesired effects or a loss of therapeutic activity.
Our innovative approach:
Rather than working on any type of pharmacology in an animal or cellular model, the work is performed directly on human tissue.
Advantages of approach
Inoviem highly recommends adopting a translational pharmacology strategy at the inception of any project, as it saves time and money.
How we work with clients
Inoviem develops new methodologies, approaches and/or technologies specifically tailored to solve each client’s unique problem.